Afternoon SPAC News Roundup: February 26, 2024
by Nicholas Alan Clayton on 2024-02-26 at 1:45pm

News and Rumors

  • PR: Medtech firm Agiliti (NYSE:AGTI) has agreed to be acquired by an affiliate of private equity firm Thomas H. Lee Partners (THL) at $10 per share and an enterprise value of $2.5 billion. This represents a 43% premium over the company’s 90-day VWAP and returns it to 100% ownership by THL five years after it combined with Federal Street at a $1.7 billion enterprise value.
  • PR: Fintech AtlasClear (NYSE:ATCH) has completed the acquisition of Pacsquare Technologies, which will help it scale the group’s cloud customer engagement tools. AtlasClear closed a combination with Quantum FinTech on February 9.
  • PR: Akili (NASDAQ:AKLI) has submitted its digital therapeutics SDT-001 for marketing approval in Japan, having received positive results in treating pediatric patients for ADHD in Phase III trials. Akili combined with Social Capital Suvretta I in August 2022.
  • SpaceNews: Intuitive Machines (NASDAQ:LUNR) expects to communicate with its IM-1 Moon lander for just one more day as it appears to have tipped over and may not be able to regularly recharge itself via solar panels. The company made the historic first commercial soft landing on the moon last week, having combined with Inflection Point in February 2023.

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

by Nicholas Alan Clayton on 2024-04-16 at 7:58am

At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...

by Nicholas Alan Clayton on 2024-04-15 at 3:47pm

AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved